
Bath & Body Works beats Q4 estimates, issues cautious 2026
Bath & Body Works (NYSE:BBWI) reported fourth-quarter 2025 results on Wednesday that exceeded its own conservative projections, though the retailer signaled a cautious road ahead with a 2026 outlook that anticipates continued sales declines.
The Columbus, Ohio-based fragrance giant posted fourth-quarter net sales of $2.7 billion.
While this represented a 2% decline compared to the prior year, the figure landed above the high end of the company’s previous guidance.
The bottom line also showed resilience, with earnings per diluted share reaching $1.99.
On an adjusted basis, which excludes certain costs related to the company's ongoing "Consumer First" transformation, earnings per share stood at $2.05.
The quarterly beat was driven by strong engagement in core categories such as body care and home fragrance during the critical holiday window.
Management noted that higher reward redemption and a 6% increase in active loyalty members—now totaling roughly 39 million—helped sustain traffic despite a promotional retail landscape and macro consumer pressures.
Despite the quarterly outperformance, Bath & Body Works provided a 2026 forecast that suggests a period of contraction ahead.
For the full year 2026, the company expects net sales to decline between 4.5% and 2.5% compared to 2025 levels.
Frequently asked questions
More from United States
AbbVie revenue increases 10.3% to $17.4 billion in third quarter
Sensient Q3 revenue rockets 10.6% to $455.8 million
Cameco Q3 adjusted loss reaches CA$2 million as uranium output falls
Kite Realty Q3 loss narrows to $13.3 million as NOI grows
Largo cuts 2026 vanadium production outlook to 9,500–10,500 tonnes
nVent Q3 sales jump 44% as shares fall despite higher revenue